Mitomycin-C

DRUG14 trials

Conditions

Anal CancerAnal Squamous Cell CarcinomaBladder CancerCarcinoma of the Anal CanalCorneal OpacityGlaucomaGlottic CarcinomaGlottic Web of Larynx

Early Phase 1

Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma

CompletedNCT01858025

Massachusetts General HospitalCarcinoma of the Anal Canal

Start: 2013-07-01End: 2021-11-01Updated: 2026-02-18

Phase 1

Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer

CompletedNCT01296763

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPancreatic Cancer

Start: 2011-01-31End: 2016-02-29Updated: 2016-03-22

Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer

TerminatedNCT01324141

National Cancer Institute (NCI)Anal Cancer

Start: 2011-03-18End: 2015-04-15Updated: 2021-11-23

Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords

RecruitingNCT05688488

Eye & ENT Hospital of Fudan UniversityGlottic Carcinoma, Glottic Web of Larynx, Laryngeal Leucoplakia +3

Start: 2023-05-05End: 2026-12-31Target: 100Updated: 2023-05-06

Phase 2

Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene

WithdrawnNCT00386399

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPancreatic Cancer

Start: 2006-10-31End: 2008-02-29Updated: 2018-07-12

The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device

CompletedNCT02016898

Duke UniversityPrimary Open Angle Glaucoma

Start: 2014-03-31End: 2017-01-17Updated: 2018-02-09

The Use of MMC During PRK and Its Effect on Postoperative Topical Steroid Requirements

NCT02030990

United States Naval Medical Center, San DiegoCorneal Opacity

Start: 2014-08-31End: 2023-07-31Target: 300Updated: 2022-04-15

Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies

CompletedNCT02369458

Washington University School of MedicineSquamous Cell Carcinoma, Head and Neck, Squamous Cell Carcinoma of the Head and Neck

Start: 2015-04-14End: 2024-11-01Updated: 2025-11-18

Ahmed Glaucoma Valve Surgery With Mitomycin-C

CompletedNCT02805257

University of California, San FranciscoGlaucoma, Neovascular Glaucoma, Primary Open Angle Glaucoma +1

Start: 2016-06-30End: 2020-03-31Updated: 2022-05-31

The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy

RecruitingNCT06388720

National Cancer Center, KoreaBladder Cancer

Start: 2024-11-19End: 2027-12-31Target: 82Updated: 2025-09-15

Phase 3

Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC

TerminatedNCT02982395

Samyang Biopharmaceuticals CorporationNon Muscle Invasive Bladder Cancer

Start: 2017-01-31End: 2018-08-31Updated: 2019-08-30

Unknown Phase

Mitomycin-c Application for PRK

CompletedNCT01504282

Shahid Beheshti University of Medical SciencesMyopia

Target: 90Updated: 2012-01-05

Surgical Approaches in Treating Uncontrolled Glaucoma in Black African and African-Caribbeans

NCT02989207

Guy's and St Thomas' NHS Foundation TrustPrimary Open Angle Glaucoma

Start: 2016-08-31End: 2017-12-31Target: 60Updated: 2016-12-12

Adaptive Radiation in Anal Cancer

RecruitingNCT05838391

Columbia UniversityAnal Squamous Cell Carcinoma

Start: 2023-05-18End: 2028-12-31Target: 20Updated: 2026-02-03

Related Papers

CT-Guided Adaptive Radiotherapy for the Treatment of Technically Challenging Oligometastatic Disease: A Case Report

Cureus2024-10-03

Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study.

2019-05-2222 citations

A pilot feasibility study of definitive concurrent chemoradiation with pencil beam scanning proton beam in combination with 5-fluorouracil and mitomycin-c for carcinoma of the anal canal.

Journal of Clinical Oncology2018-02-013 citations

Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer

Oncotarget2017-04-1979 citations